International Biotechnology Trust plc Strategic Asset Allocation Index
International Biotechnology Trust plc strategic asset allocation index. International Biotechnology Trust plc (IBT) has a Strategic Asset Allocation Index of 107.8% as of August 2025. Strategic assets (PP&E of GBX- plus long-term investments of GBX268.92 Million) total GBX268.92 Million, measured against net assets of GBX249.41 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See International Biotechnology Trust plc balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of International Biotechnology Trust plc (2014–2025)
Strategic asset allocation index of International Biotechnology Trust plc from 2014 to 2025. This chart shows how International Biotechnology Trust plc's Strategic Asset Allocation Index has evolved across 12 annual periods from 2014 to 2025. As of August 2025, the index stands at 107.8%, representing strategic assets of GBX268.92 Million against net assets of GBX249.41 Million GBX. Check International Biotechnology Trust plc (IBT) tangible equity ratio to evaluate the tangible quality of the company's equity base.
International Biotechnology Trust plc Strategic Asset Allocation Index by Year (2014–2025)
International Biotechnology Trust plc strategic asset allocation index by year from 2014 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for International Biotechnology Trust plc from 2014 to 2025, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see International Biotechnology Trust plc stock valuation.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 107.8% | GBX268.92 Million | GBX- | GBX268.92 Million | GBX249.41 Million | ▲ +2.4 pp |
| 2024 | 105.4% | GBX297.51 Million | GBX- | GBX297.51 Million | GBX282.26 Million | ▼ -6.3 pp |
| 2023 | 111.7% | GBX301.90 Million | GBX- | GBX301.90 Million | GBX270.32 Million | ▲ +1.7 pp |
| 2022 | 110.0% | GBX313.43 Million | GBX- | GBX313.43 Million | GBX284.89 Million | ▲ +3.4 pp |
| 2021 | 106.7% | GBX345.34 Million | GBX- | GBX345.34 Million | GBX323.77 Million | ▲ +0.2 pp |
| 2020 | 106.5% | GBX302.22 Million | GBX- | GBX302.22 Million | GBX283.90 Million | ▲ +7.9 pp |
| 2019 | 98.6% | GBX237.36 Million | GBX- | GBX237.36 Million | GBX240.82 Million | ▼ -1.6 pp |
| 2018 | 100.2% | GBX263.02 Million | GBX- | GBX263.02 Million | GBX262.47 Million | ▼ -6.4 pp |
| 2017 | 106.6% | GBX269.37 Million | GBX- | GBX269.37 Million | GBX252.65 Million | ▲ +4.2 pp |
| 2016 | 102.4% | GBX221.79 Million | GBX- | GBX221.79 Million | GBX216.65 Million | ▼ -2.3 pp |
| 2015 | 104.6% | GBX246.93 Million | GBX- | GBX246.93 Million | GBX236.00 Million | ▲ +0.1 pp |
| 2014 | 104.5% | GBX224.72 Million | GBX- | GBX224.72 Million | GBX214.97 Million | — |